RAPID VIROLOGICAL RESPONSE(RVR) VS IL28B CC GENOTYPE IN HCV-1 INFECTED PATIENTS TREATED WITH AN INDIVIDUALIZED COURSE OF PEGINTERFERON (PEGIFN) AND WEIGHT BASED RIBAVRIN (RBV)

被引：0
|
作者：
Mangia, Alessandra [1 ]
Thompson, Alexander J. [2 ]
Santoro, Rosanna [1 ]
Mottola, Leonardo [1 ]
Piazzolla, Valeria [1 ]
Petruzzellis, Daniela [1 ]
Minerva, Nicola [3 ]
Bacca, Donato [4 ]
Goldstein, David B. [5 ]
McHutchison, John G. [2 ]
机构：
[1] IRCCS, Liver Unit, San Giovanni Rotondo, Italy
[2] Duke Clin Res Inst, Durham, NC USA
[3] Hosp Canosa, Canosa, Italy
[4] F Ferrari Hosp, Casarano, Italy
[5] Duke Univ, Ctr Human Genome Variat, Inst Genome Sci & Policy, Durham, NC USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
897
引用
收藏
页码：750A / 751A
页数：2
相关论文
共 46 条
  • [21] DIFFERENT IMPACT OF IL28B POLYMORPHISMS ON RESPONSE TO PEGINTERFERON-α PLUS RIBAVIRIN IN HIV-POSITIVE PATIENTS INFECTED WITH HCV SUBTYPES 1A OR 1B
    Vispo, Eugenia
    Rallon, Norma I.
    Tellez, Maria
    Barreiro, Pablo
    Benito, Jose M.
    Soriano, Vincent
    HEPATOLOGY, 2011, 54 : 811A - 811A
  • [22] Association between IL28B gene polymorphism (rs12979860) and sustained virological response in patients infected with hepatitis C virus Genotype 1
    Akkiz, Hikmet
    Sezgin, Orhan
    Altintas, Engin
    Yalcin, Kendal
    Ekin, Nazim
    Uskudar, Oguz
    Sandikci, Macit U.
    Bayram, Suleyman
    Bekar, Aynur
    Akgollu, Ersin
    Kuran, Sedef
    Yildirim, Selcuk
    HEPATOLOGY, 2012, 56 : 1051A - 1051A
  • [23] Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b
    Vispo, Eugenia
    Rallon, Norma I.
    Labarga, Pablo
    Barreiro, Pablo
    Miguel Benito, Jose
    Soriano, Vincent
    JOURNAL OF CLINICAL VIROLOGY, 2012, 55 (01) : 58 - 61
  • [24] IL28B CC-genotype association with HLA-DQB1*0301 allele increases the prediction of spontaneous HCV RNA clearance in thalassaemic HCV-infected patients
    Mangia, Alessandra
    Santoro, Rosanna
    Sarli, Roberto
    Mottola, Leonardo
    Piazzolla, Valeria
    Petruzzellis, Daniela
    Bacca, Donato
    Clemente, Rocco
    Copetti, Massimiliano
    di Mauro, Lazzaro
    Lotti, Giuseppe
    Sacco, Michele
    Stefano, Ippazio
    ANTIVIRAL THERAPY, 2011, 16 (08) : 1309 - 1316
  • [25] Hepatitis C virus (HCV) genotype 1 (G1) infection with low viral load (LVL) and rapid virologic response (RVR) to peginterferon and ribavirin (PEG/RBV) can be treated without a protease inhibitor (PI), irrespective of IL-28B status or patient ethnicity
    Pearlman, Brian
    Ehleben, Carole
    HEPATOLOGY, 2012, 56 : 268A - 268A
  • [26] DYSREGULATION OF HOST INNATE IMMUNITY IN HCV GENOTYPE 1 INFECTED IL28B CT/TT HAPLOTYPE PATIENTS WITH DEPRESSED VIRAL KINETICS AND THERAPEUTIC RESPONSE
    Naggie, S.
    Osinusi, A.
    Katsounas, A.
    Lempicki, R.
    Herrmann, E.
    Shivakumar, B.
    Thompson, A.
    Clark, P.
    Patel, K.
    Muir, A.
    Mchutchison, J.
    Goldstein, D.
    Schlaak, J.
    Masur, H.
    Polis, M.
    Kottilil, S.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S526 - S527
  • [27] THE EFFECTS OF IL28B AND ITPA GENOTYPES ON ANTIVIRAL RESPONSE AND HEMOLYTIC ANEMIA IN HCV GENOTYPE 1 PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY
    Choi, J.
    Kim, H.
    Park, S.
    Oh, M.
    Jung, E.
    Lee, Y.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S25 - S25
  • [28] Sustained virological response (SVR) rate of 67% in HCV genotype 1-infected prior null responders treated with danoprevir/ritonavir (DNVr) in combination with peginterferon alfa-2a (40KD) plus ribavirin (PegIFNα-2a/RBV)
    Gane, Edward J.
    Rouzier, Regine
    Wiercinska-Drapalo, Alicia
    Larrey, Dominique G.
    Bhardwaj, Rajinder
    Brennan, Barbara J.
    Giraudon, Mylene
    Le Pogam, Sophie
    Najera, Isabel
    Petric, Rosemary
    Jonathan Tran
    Zhang, Ying
    Smith, Patrick F.
    Yetzer, Ellen S.
    Shulman, Nancy
    HEPATOLOGY, 2012, 56 : 558A - 558A
  • [29] IL28B SNP, ITPA SNP AND MUTATION OF CORE REGION AND INTERFERON SENSITIVITY DETERMINING REGION OF HCV: THEIR EFFECTS ON THE RESPONSE TO PEG-IFN/RBV THERAPY IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 INFECTION
    Murao, Michihito
    Yoshioka, Kentaro
    Hashimoto, Senju
    Kawabe, Naoto
    Harata, Masao
    Nitta, Yoshifumi
    Nakano, Takuji
    Arima, Yuko
    Shimazaki, Hiroaki
    HEPATOLOGY, 2011, 54 : 853A - 853A
  • [30] PRE-TREATMENT IP-10 LEVELS AND IL28B GENOTYPE IN PREDICTION OF SVR IN PRIOR TREATMENT-EXPERIENCED GENOTYPE 1 HCV PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/ RIBAVIRIN IN THE REALIZE STUDY
    Vijgen, L.
    Talloen, W.
    Scholliers, A.
    Johansson, S.
    Tuefferd, M.
    De Meyer, S.
    Witek, J.
    Fanning, G.
    Picchio, G.
    Pol, S.
    Zeuzem, S.
    Aerssens, J.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S462 - S462
12345